"Designing Growth Strategies is in our DNA"

Precision Diagnostics Market Size, Share & Industry Analysis, By Type (Genetic Tests, Esoteric Tests, and Others), By Application (Oncology, Cardiovascular, Neurology, and Others), By End User (Hospitals, Clinical Laboratories, and Homecare), and Regional Forecast, 2024-2032

Last Updated: January 20, 2025 | Format: PDF | Report ID: FBI100357

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Unit

Value (USD Billion)

Growth Rate 

CAGR of 13.1% from 2024-2032

Segmentation

By Type

  • Genetic Tests
  • Esoteric Tests
  • Others

By Application

  • Oncology
  • Cardiovascular
  • Neurology
  • Others

By End User

  • Hospitals
  • Clinical Laboratories
  • Homecare

By Geography

  • North America (By Type, By Application, By End User, and By Country)
    • U.S. (By Type)
    • Canada (By Type)
  • Europe (By Type, By Application, By End User, and By Country/Sub-region)
    • U.K. (By Type)
    • Germany (By Type)
    • France (By Type)
    • Italy (By Type)
    • Spain (By Type)
    • Scandinavia (By Type)
    • Rest of Europe (By Type)
  • Asia Pacific (By Type, By Application, By End User, and By Country/Sub-region)
    • China (By Type)
    • Japan (By Type)
    • India (By Type)
    • Australia (By Type)
    • Southeast Asia (By Type)
    • Rest of Asia Pacific (By Type)
  • Latin America (By Type, By Application, By End User, and By Country/Sub-region)
    • Brazil (By Type)
    • Mexico (By Type)
    • Rest of Latin America (By Type)
  • Middle East & Africa (By Type, By Application, By End User, and By Country/Sub-region)
    • GCC (By Type)
    • South Africa (By Type)
    • Rest of Middle East & Africa (By Type)
  • 2019-2032
  • 2023
  • 2019-2022
  • 140
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X